Isoplex-HF Tablet

Isosorbide Dinitrate 20 mg + Hydralazine 37.5 mg

Isoplex-HF Tablet — Isosorbide Dinitrate 20 mg + Hydralazine 37.5 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Isosorbide Dinitrate 20 mg + Hydralazine 37.5 mg
Dosage Form Tablet
Pack Type Box
Pack Size 10 x 10 (Alu Alu)
MRP ₹ 1100
Therapy Cardiac + Diabetic — Venous nitrate + arterial vasodilator combination (heart failure)
Storage Store below 25°C.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Isoplex-HF Tablet

Isoplex-HF Tablet combines the venous nitrate Isosorbide Dinitrate 20 mg with the arterial vasodilator Hydralazine 37.5 mg. The combination is established in heart failure with reduced ejection fraction — particularly in African-American patients (A-HeFT trial showed mortality benefit).

It is indicated as add-on therapy in heart failure with reduced ejection fraction (HFrEF), in patients intolerant to ACE inhibitors/ARBs, and in chronic refractory heart failure on optimal background therapy.

Camrut Healthcare manufactures Isoplex-HF under WHO-GMP conditions for PCD pharma franchise across India.

Indications

  • Heart failure with reduced ejection fraction (HFrEF)
  • HF in African-origin patients on background ACE inhibitor / ARB therapy
  • ACE inhibitor / ARB-intolerant patients with HF
  • Chronic refractory heart failure

Mechanism of Action

Isosorbide Dinitrate is converted to nitric oxide in vascular smooth muscle, predominantly venodilating and reducing preload. Hydralazine is a direct arterial vasodilator (mechanism uncertain — possibly through release of nitric oxide and inhibition of inositol triphosphate-induced calcium release). The combination provides balanced reduction in preload and afterload.

Dosage & Administration

['Adults: 1 tablet three times daily (titrate from lower starting dose)', 'Take with food to reduce GI side effects', 'Use under cardiologist supervision', 'Monitor BP and renal function']

Side Effects

['Headache (very common — nitrate-mediated)', 'Postural hypotension', 'Reflex tachycardia', 'SLE-like syndrome (hydralazine, dose-dependent)', 'Fluid retention']

Contraindications & Precautions

['Severe aortic stenosis', 'Hypertrophic obstructive cardiomyopathy', 'Recent MI with hypotension', 'Concurrent PDE-5 inhibitors (Sildenafil etc)', 'Hydralazine-induced SLE history']

Storage

Store below 25°C.

PCD Pharma Franchise & Third-Party Manufacturing
Isoplex-HF Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.